POCINASDAQHealthcare

Public company intelligence preview

PRECISION OPTICS CORPORATION INC

15 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
15
0 filed in the last 30 days
Acquisition / disposition count
13/2
Buy / Sell
Unique insiders active in the last year
7
Current insider positions tracked
19
18 active, 1 exited

Insider compensation

Public aggregate: $332674.95 average total compensation across covered insiders.

Governance movement

Public aggregate: 1 governance events in the last year.

Institutional ownership

Public aggregate: 20 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
0
Restricted-sale insiders, 1Y
0
Planned sale shares, 1Y
0
Planned sale value, 1Y
$0.00
Insiders covered
6
Latest year: 2025
Personnel changes, 1Y
1
Board appointments, 1Y
1
Board departures, 1Y
1

Market context

Basic quote context for the preview.

Price
$4.97
Market cap
$54.0M
Volume
102,778
EPS
$-0.01
Revenue
$8.7M
Employees
90

Company note

Context before the data.

Company Overview

Precision Optics Corporation Inc. is a niche developer and manufacturer of advanced optical instruments for the Healthcare sector, specifically the Medical Instruments & Supplies industry, with additional exposure to defense and aerospace markets. Its core business includes minimally invasive surgical imaging products such as endoscopes, microprecision lenses, camera modules, and custom optical assemblies, with recent emphasis on the Unity Imaging Platform and single-use digital CMOS systems. The company also operates engineering services, Ross Optical components, and a micro-optics lab, and it serves U.S. medical OEMs and defense/aerospace customers. Recent filings show a business in transition: systems manufacturing has been growing quickly, while engineering design revenue has declined as programs move from development into production.

Executive Compensation Practices

Executive compensation at a company like this is likely to be heavily influenced by revenue growth, manufacturing scale-up, gross margin improvement, and successful commercialization of new platforms rather than just top-line growth alone. For Precision Optics, recent filings suggest pay incentives may be tied to operational milestones such as converting engineering programs into production, improving yields on new manufacturing lines, and expanding utilization of proprietary platforms like the Unity Imaging Platform. Stock-based compensation appears material in SG&A, which is common for smaller healthcare technology manufacturers using equity to conserve cash and align management with long-term turnaround and growth objectives. Because the company has also cited going-concern risk, covenant pressure, and the need for outside financing, compensation structures may include retention-focused awards or short-term cash incentives linked to liquidity management and financing execution.

Insider Trading Considerations

Insider trading activity in the Medical Instruments & Supplies industry can be especially sensitive to product launch timing, regulatory approvals, customer wins, and manufacturing execution, all of which are highly material for Precision Optics. The company’s revenue depends on a small number of customers and suppliers, so insiders may have meaningful nonpublic insight into order timing, line yields, and the conversion of development projects into recurring production revenue. The recent deterioration in gross margin, covenant compliance issues, and explicit going-concern language make financing events and operational updates particularly market-moving, which can affect insider transaction patterns around disclosure windows. In a business with defense/aerospace exposure and FDA-related regulatory considerations, insiders are also likely subject to heightened trading caution because product delays, clearance updates, or customer reorders can materially change outlook quickly.

Unlock the full POCI insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.